Fresenius SE & Co. KGaA



 


WELCOME TO FRESENIUS SE

Fresenius - the health care group

Fresenius is a global health care group with products and services for dialysis, the hospital and the medical care of patients at home.

The Fresenius Group consists of the following four business segments that are responsible for their own business operations worldwide: Fresenius Medical Care, Fresenius KabiFresenius Helios and Fresenius Vamed.


Latest news

18.05.2012
Fresenius publishes offer document for the takeover of RHÖN-KLINIKUM AG – Acceptance period expires June 27, 2012

Der Gesundheitskonzern Fresenius hat heute über seine Tochtergesellschaft FPS Beteiligungs AG ein freiwilliges öffentliches Übernahmeangebot an die Aktionäre der RHÖN-KLINIKUM AG veröffentlicht. Fresenius bietet den Aktionären der RHÖN-KLINIKUM AG 22,50 € pro Aktie in bar an.

>>>
11.05.2012
Fresenius SE & Co. KGaA Annual General Meeting: Health care group confirms outlook 2012, 19th consecutive dividend increase

Fresenius is aiming for new record sales and earnings this year. Ulf Mark Schneider, CEO of Fresenius, confirmed the Group outlook 2012 at the company’s Annual General Meeting in Frankfurt today.

>>>
11.05.2012
Fresenius successfully completes capital increase

Fresenius successfully placed 13.8 million new ordinary shares today.

>>>
10.05.2012
Fresenius resolves on capital increase of approx. €1 billion

Fresenius resolved today to issue 13.8 million new ordinary shares from authorized capital excluding subscription rights.

>>>
10.05.2012
Fresenius Medical Care expects continued strong growth – Shareholders approve 15th consecutive dividend increase

Fresenius Medical Care expects another record result for 2012. At the annual general meeting in Frankfurt am Main today, Dr. Ben Lipps, the company’s chief executive officer, confirmed the full-year outlook.

>>>